Table 1 Baseline characteristics.
Overall (N = 123) | EIPH (N = 57) | No-EIPH (N = 66) | p-value | |
|---|---|---|---|---|
Age, years old | 65.4 ± 15.3 | 70.4 ± 10.7 | 61.1 ± 17.3 | < 0.001 |
< 50 years old, n (%) | 20 (16) | 3 (5) | 17 (26) | 0.002 |
Sex (male), n (%) | 68 (55) | 34 (60) | 34 (52) | 0.37 |
Body surface area, m2 | 1.61 ± 0.19 | 1.63 ± 0.17 | 1.60 ± 0.20 | 0.34 |
Atrial fibrillation, n (%) | 18 (15) | 8 (14) | 10 (15) | 0.86 |
NYHA II, n (%) | 53 (43) | 31 (54) | 22 (33) | 0.019 |
Hypertension, n (%) | 58 (47) | 32 (56) | 26 (39) | 0.064 |
Diabetes, n (%) | 6 (4.9) | 1 (1.8) | 5 (7.6) | 0.14 |
Current or previous smoking, n (%) | 27 (22) | 16 (28) | 11 (17) | 0.13 |
Hyper lipidemia, n (%) | 36 (29) | 21 (37) | 15 (23) | 0.086 |
Previous PCI, n (%) | 2 (1.6) | 1 (1.8) | 1 (1.5) | 0.92 |
Previous cerebral infarction, n (%) | 1 (0.8) | 1 (1.8) | 0 | 0.28 |
Hemoglobin, g/dL | 13.6 ± 1.4 | 13.4 ± 1.4 | 13.8 ± 1.3 | 0.21 |
Creatinine, mg/dL | 0.86 ± 0.25 | 0.86 ± 0.24 | 0.86 ± 0.25 | 0.98 |
Estimated glomerular filtration rate, mL/min/1.73m2 | 65.3 ± 16.6 | 62.9 ± 14.1 | 67.4 ± 18.4 | 0.14 |
Brain natriuretic peptide, pg/mL | 42.7 (20.1–96.3) | 63.2 (35.0–136.1) | 27.6 (15.3–81.2) | 0.097 |
